Loading clinical trials...
Loading clinical trials...
A Randomized, Double-blind Study Comparing the Effect of Different Treatment Regimens of Intravenous Bonviva on Lumbar Bone Mineral Density in Women With Osteoporosis
This study will assess the efficacy and safety of intravenous administration of Bonviva regimens in women with post-menopausal osteoporosis, compared to oral daily administration. Patients will also receive daily supplementation with vitamin D and calcium. The anticipated time of study treatment is 2+ years, and the target sample size is 500+ individuals.
Age
55 - 80 years
Sex
FEMALE
Healthy Volunteers
No
Little Rock, Arkansas, United States
Irvine, California, United States
Rancho Mirage, California, United States
Leesburg, Florida, United States
Gainesville, Georgia, United States
Coeur d'Alene, Idaho, United States
Bethesda, Maryland, United States
St Louis, Missouri, United States
Billings, Montana, United States
Omaha, Nebraska, United States
Start Date
June 1, 2002
Primary Completion Date
May 1, 2005
Completion Date
May 1, 2005
Last Updated
February 3, 2016
1,395
ACTUAL participants
ibandronate [Bonviva/Boniva]
DRUG
ibandronate [Bonviva/Boniva]
DRUG
ibandronate [Bonviva/Boniva]
DRUG
Lead Sponsor
Hoffmann-La Roche
NCT05571514
NCT02347865
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT00377234